Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

VTGN holding history

Vistagen Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VTGN overviewAll 13F holders of VTGNFull Q2 2026 holdings

Shares (Q2 2026)
68,839
Value
$15.6K
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of VTGN by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202668,839$15.6K<0.1%+68,839NewHolders
Q4 20250$00.0%−122,062−100.0%Sold outHolders
Q3 2025122,062$433.3K<0.1%+122,062NewHolders
Q4 20240$00.0%−321,885−100.0%Sold outHolders
Q3 2024321,885$968.9K<0.1%−307,760−48.9%ReducedHolders
Q2 2024629,645$2.19M<0.1%−114,275−15.4%ReducedHolders
Q1 2024743,920$3.93M<0.1%+425+0.1%AddedHolders
Q4 2023743,495$3.82M<0.1%+734,943+8,593.8%AddedHolders
Q3 20238,552$44.8K<0.1%−11,319−57.0%ReducedHolders
Q2 202319,871$37.2K<0.1%+19,282+3,272.9%AddedConverted for a 1-for-30 splitHolders
Q1 202317,674$2.20K<0.1%−211,833−92.3%ReducedHolders
Q4 2022229,507$23.6K<0.1%+126,809+123.5%AddedHolders
Q3 2022102,698$16.0K<0.1%−1,188,285−92.0%ReducedHolders
Q2 20221,290,983$1.14M<0.1%+246,168+23.6%AddedHolders
Q1 20221,044,815$1.30M<0.1%+908,821+668.3%AddedHolders
Q4 2021135,994$266.0K<0.1%+9,864+7.8%AddedHolders
Q3 2021126,130$346.0K<0.1%+114,175+955.0%AddedHolders
Q2 202111,955$38.0K<0.1%−96,245−89.0%ReducedHolders
Q1 2021108,200$230.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.